# Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

> **NCT03779061** · PHASE3 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 388 (actual)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** Remimazolam Tosilate
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03779061
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2018-09-20
- **Final completion:** 2018-09-28
- **Target enrollment:** 388 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779061, "Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03779061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*